Evidence map›Paper›PMID 20471282›Full record

ReviewSeminars in immunology2010

Towards a molecular understanding of the differential signals regulating alphabeta/gammadelta T lineage choice.

Sang-Yun Lee, Jason Stadanlick, Dietmar J Kappes, David L Wiest

Abstract readReview
In one paragraph

Review in Seminars in immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Development of αβ and γδ T Cells in the Thymus and Methods of Analysis.International journal of molecular sciences · 2025
    Review
  3. HEB collaborates with TCR signaling to upregulatebioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Development of γδ T Cells: Soldiers on the Front Lines of Immune Battles.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Nodal EBV+ cytotoxic T-cell lymphoma: A literature review based on the 2017 WHO classification.Journal of clinical and experimental hematopathology : JCEH · 2020
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sang-Yun LeeImmune Cell Development and Host Defense Program, Blood Cell Development and Cancer Keystone, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.
Jason Stadanlick
Dietmar J Kappes
David L Wiest

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
TRANSGENIC AND CHIMERIC MOUSE COREP30DK050306 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Ken Hashigiwa Cadwell · 1997 to 2026
$32.5M
TRAINING PROGRAM IN CANCER RESEARCHT32CA009035 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI CHERNOFF, JONATHAN · 1985 to 2020
$10.5M
Control of alpha-beta/gamma-delta T Lineage CommitmentR01AI081314 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI WIEST, DAVID L. · 2009 to 2013
$2.1M
Role of RPL22 in Thymocyte DevelopmentR01AI073920 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI WIEST, DAVID L. · 2007 to 2011
$2.1M
Transcriptional Control of Th-POK, a Key Regulator of Lineage ControlR01AI068907 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI KAPPES, DIETMAR J · 2008 to 2011
$2.0M
Control of Lineage Commitment in Developing ThymocytesR01CA153260 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI KAPPES, DIETMAR J · 2010 to 2014
$1.9M
Role of RPL22 in Thymocyte DevelopmentR56AI073920 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI WIEST, DAVID L. · 2012 to 2012
$446k
NCI NIH HHS P01CA06927NCI NIH HHS P30 CA006927NCI NIH HHS R01 CA153260NCI NIH HHS T32 CA009035NIAID NIH HHS AI073920NIAID NIH HHS AI081814NIAID NIH HHS R01 AI068907NIAID NIH HHS R01 AI073920NIAID NIH HHS R01 AI081314NIAID NIH HHS R56 AI073920NIDDK NIH HHS P30 DK050306NIDDK NIH HHS P30-DK-50306
6 · The paper itself

Abstract

While insights into the molecular processes that specify adoption of the alphabeta and gammadelta fates are beginning to emerge, the basis for control of specification remains highly controversial. This review highlights the current models attempting to explain T lineage commitment. Recent observations support the hypothesis that the T cell receptor (TCR) provides instructive cues through differences in TCR signaling intensity and/or longevity. Accordingly, we review evidence addressing the importance of differences in signal strength/longevity, how signals differing in intensity/longevity may be generated, and finally how such signals modulate the activity of downstream effectors to promote the opposing developmental fates.

Indexed as

Cell LineageSignal TransductionAnimalsHumansModels, ImmunologicalReceptors, Antigen, T-Cell, alpha-betaReceptors, Antigen, T-Cell, gamma-deltaT-LymphocytesReceptors, Antigen, T-Cell, alpha-betaReceptors, Antigen, T-Cell, gamma-delta

Identifiers

PMID20471282
PMCPMC2906684

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.